Financials Agfa-Gevaert NV

Equities

AGFB

BE0003755692

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles 11:35:29 2024-07-12 am EDT 5-day change 1st Jan Change
1.208 EUR -0.98% Intraday chart for Agfa-Gevaert NV +0.50% -17.82%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 774.7 654.2 608.3 413.4 227.6 187 - -
Enterprise Value (EV) 1 993.7 654.2 281.3 413.4 233.6 222.9 263.8 283.5
P/E ratio -14.4 x - -34.5 x -1.89 x -2.23 x -24.2 x 20.1 x 7.11 x
Yield - - - - - - - -
Capitalization / Revenue 0.35 x 0.38 x 0.35 x 0.22 x 0.2 x 0.16 x 0.15 x 0.15 x
EV / Revenue 0.44 x 0.38 x 0.16 x 0.22 x 0.2 x 0.19 x 0.21 x 0.22 x
EV / EBITDA 5.52 x 6.61 x 2.71 x 4.4 x 3.07 x 3.15 x 2.9 x 2.84 x
EV / FCF - -3.52 x -1.98 x - -3.65 x -7.74 x -17.7 x 18.9 x
FCF Yield - -28.4% -50.5% - -27.4% -12.9% -5.65% 5.29%
Price to Book - 1.15 x 1.01 x - - 0.46 x 0.46 x 0.45 x
Nbr of stocks (in thousands) 167,751 167,751 160,507 154,821 154,821 154,821 - -
Reference price 2 4.618 3.900 3.790 2.670 1.470 1.208 1.208 1.208
Announcement Date 3/11/20 3/10/21 3/9/22 3/8/23 3/13/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,239 1,709 1,760 1,857 1,150 1,182 1,232 1,281
EBITDA 1 180 99 104 94 76 70.75 91.01 99.85
EBIT 1 124 36 42 31 31 29.86 51.72 -
Operating Margin 5.54% 2.11% 2.39% 1.67% 2.7% 2.53% 4.2% -
Earnings before Tax (EBT) 1 - -83 1 -181 -35 -12.2 1.1 15.9
Net income 1 -53 613 -17 -221 -102 -23.2 8 25.7
Net margin -2.37% 35.87% -0.97% -11.9% -8.87% -1.96% 0.65% 2.01%
EPS 2 -0.3200 - -0.1100 -1.410 -0.6600 -0.0500 0.0600 0.1700
Free Cash Flow 1 - -186 -142 - -64 -28.8 -14.9 15
FCF margin - -10.88% -8.07% - -5.57% -2.44% -1.21% 1.17%
FCF Conversion (EBITDA) - - - - - - - 15.02%
FCF Conversion (Net income) - - - - - - - 58.37%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/11/20 3/10/21 3/9/22 3/8/23 3/13/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 439 484 - 469 474 270 280 - 250 293.7 286.2 324.2
EBITDA 1 - - - - - - - - 2 14.7 18.2 31.8
EBIT 1 - 11 - 16 7 - 6 21 -9 - - -
Operating Margin - 2.27% - 3.41% 1.48% - 2.14% - -3.6% - - -
Earnings before Tax (EBT) -4 - - - - -14 - - - - - -
Net income -5 - -4 - - -68 - - - - - -
Net margin -1.14% - - - - -25.19% - - - - - -
EPS -0.0300 - -0.0200 - - - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 11/9/21 3/9/22 5/10/22 8/24/22 11/9/22 5/9/23 11/15/23 3/13/24 5/14/24 - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 219 - - - 6 35.9 76.8 96.5
Net Cash position 1 - - 327 - - - - -
Leverage (Debt/EBITDA) 1.217 x - - - 0.0789 x 0.5067 x 0.8433 x 0.9664 x
Free Cash Flow 1 - -186 -142 - -64 -28.8 -14.9 15
ROE (net income / shareholders' equity) - - -2.83% - -22.3% -2.1% 2.1% 4.8%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - 3.390 3.770 - - 2.600 2.620 2.700
Cash Flow per Share 2 - -0.9100 -0.7500 - -0.1900 -0.0500 0.0100 -
Capex 1 - 33 26 - 34 50 45 33.8
Capex / Sales - 1.93% 1.48% - 2.96% 4.23% 3.65% 2.64%
Announcement Date 3/11/20 3/10/21 3/9/22 3/8/23 3/13/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.208 EUR
Average target price
1.833 EUR
Spread / Average Target
+51.77%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. AGFB Stock
  4. Financials Agfa-Gevaert NV